{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:01:31Z","timestamp":1784116891259,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11916-021-00987-8","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T19:02:36Z","timestamp":1636657356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research"],"prefix":"10.1007","volume":"25","author":[{"given":"Edoardo","family":"Caronna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-4702","authenticated-orcid":false,"given":"Patricia","family":"Pozo-Rosich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"issue":"3","key":"987_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141\u201354. https:\/\/doi.org\/10.1038\/s41579-020-00459-7.","journal-title":"Nat Rev Microbiol"},{"key":"987_CR2","unstructured":"WHO Coronavirus Disease (COVID-19). Dashboard. https:\/\/covid19.who.int. Accessed 15 Mar 2021."},{"key":"987_CR3","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19). Situation report \u2013 51. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.\u00a0Accessed 25 Mar 2021."},{"issue":"5","key":"987_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533\u20134. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1.","journal-title":"Lancet Infect Dis"},{"issue":"7830","key":"987_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516\u201327. https:\/\/doi.org\/10.1038\/s41586-020-2798-3.","journal-title":"Nature"},{"issue":"11","key":"987_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","volume":"16","author":"A Pezzini","year":"2020","unstructured":"Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636\u201344. https:\/\/doi.org\/10.1038\/s41582-020-0398-3.","journal-title":"Nat Rev Neurol"},{"key":"987_CR7","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"987_CR8","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/coronavirus-disease-answers?query=symptoms&referrerPageUrl=https%3A%2F%2Fwww.who.int. Accessed 10 Apr 2021."},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683\u201390. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127.","journal-title":"JAMA Neurol"},{"issue":"11","key":"987_CR10","doi-asserted-by":"publisher","first-page":"562634","DOI":"10.3389\/fneur.2020.562634","volume":"2020","author":"MA Islam","year":"2019","unstructured":"Islam MA, Alam SS, Kundu S, Hossan T, Kamal MA, Cavestro C. Prevalence of headache in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of 14,275 patients. Front Neurol. 2019;2020(11):562634. https:\/\/doi.org\/10.3389\/fneur.2020.562634.","journal-title":"Front Neurol"},{"key":"987_CR11","doi-asserted-by":"publisher","unstructured":"Gonzalez-Martinez A, Fanjul V, Ramos C, et al. Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case\u2013control study. Eur J Neurol 2021. https:\/\/doi.org\/10.1111\/ene.14718.","DOI":"10.1111\/ene.14718"},{"key":"987_CR12","doi-asserted-by":"publisher","unstructured":"\u2022 Trigo J, Garc\u00eda-Azor\u00edn D, Planchuelo-G\u00f3mez \u00c1, et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain.\u00a02020;21(1):94. https:\/\/doi.org\/10.1186\/s10194-020-01165-8. This retrospective study shows lower mortality in COVID-19 hospitalized patients with headache.","DOI":"10.1186\/s10194-020-01165-8"},{"key":"987_CR13","doi-asserted-by":"publisher","unstructured":"\u2022 Caronna E, Ballv\u00e9 A, Llaurad\u00f3 A, et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia.\u00a02020;40(13):1410\u20131421. https:\/\/doi.org\/10.1177\/0333102420965157. This is the first prospective study conducted in COVID-19 patients, specifically evaluating and characterizing headache from the acute setting of the disease up to 6 weeks.","DOI":"10.1177\/0333102420965157"},{"issue":"13","key":"987_CR14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1177\/0333102420965140","volume":"40","author":"R Magdy","year":"2020","unstructured":"Magdy R, Hussein M, Ragaie C, et al. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: a cross sectional study. Cephalalgia. 2020;40(13):1422\u201331. https:\/\/doi.org\/10.1177\/0333102420965140.","journal-title":"Cephalalgia"},{"issue":"13","key":"987_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/0333102420966770","volume":"40","author":"PAS Rocha-Filho","year":"2020","unstructured":"Rocha-Filho PAS, Magalh\u00e3es JE. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia. Cephalalgia. 2020;40(13):1443\u201351. https:\/\/doi.org\/10.1177\/0333102420966770.","journal-title":"Cephalalgia"},{"key":"987_CR16","doi-asserted-by":"publisher","unstructured":"Membrilla JA, de Lorenzo \u00cd, Sastre M, D\u00edaz de Ter\u00e1n J. Headache as a cardinal symptom of coronavirus disease 2019: a cross-sectional study. Headache.\u00a02020;60(10):2176\u20132191. https:\/\/doi.org\/10.1111\/head.13967","DOI":"10.1111\/head.13967"},{"issue":"10","key":"987_CR17","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1111\/head.13923","volume":"60","author":"L Poncet-Megemont","year":"2020","unstructured":"Poncet-Megemont L, Paris P, Tronchere A, et al. High prevalence of headaches during COVID-19 infection: a retrospective cohort study. Headache. 2020;60(10):2578\u201382. https:\/\/doi.org\/10.1111\/head.13923.","journal-title":"Headache"},{"issue":"7","key":"987_CR18","doi-asserted-by":"publisher","first-page":"ofaa271","DOI":"10.1093\/ofid\/ofaa271","volume":"7","author":"MF Pullen","year":"2020","unstructured":"Pullen MF, Skipper CP, Hullsiek KH, et al. Symptoms of COVID-19 outpatients in the United States. Open Forum Infect Dis. 2020;7(7):ofaa271. https:\/\/doi.org\/10.1093\/ofid\/ofaa271.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"987_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10194-020-01188-1","volume":"21","author":"\u00d6 Uygun","year":"2020","unstructured":"Uygun \u00d6, Erta\u015f M, Ekizo\u011flu E, et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain. 2020;21(1):121. https:\/\/doi.org\/10.1186\/s10194-020-01188-1.","journal-title":"J Headache Pain"},{"issue":"13","key":"987_CR20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1177\/0333102420965146","volume":"40","author":"JT L\u00f3pez","year":"2020","unstructured":"L\u00f3pez JT, Garc\u00eda-Azor\u00edn D, Planchuelo-G\u00f3mez \u00c1, Garc\u00eda-Iglesias C, Due\u00f1as-Guti\u00e9rrez C, Guerrero \u00c1L. Phenotypic characterization of acute headache attributed to SARS-CoV-2: an ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020;40(13):1432\u201342. https:\/\/doi.org\/10.1177\/0333102420965146.","journal-title":"Cephalalgia"},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/head.13902","volume":"60","author":"J Porta-Etessam","year":"2020","unstructured":"Porta-Etessam J, Mat\u00edas-Guiu JA, Gonz\u00e1lez-Garc\u00eda N, et al. Spectrum of headaches associated with SARS-CoV-2 infection: study of healthcare professionals. Headache. 2020;60:1697\u2013704. https:\/\/doi.org\/10.1111\/head.13902.","journal-title":"Headache"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/head.13890","volume":"60","author":"J Singh","year":"2020","unstructured":"Singh J, Ali A. Headache as the presenting symptom in 2 patients with COVID-19 and a history of migraine: 2 case reports. Headache. 2020;60:1773\u20136. https:\/\/doi.org\/10.1111\/head.13890.","journal-title":"Headache"},{"issue":"4","key":"987_CR23","first-page":"233","volume":"32","author":"A Gil-Rodrigo","year":"2020","unstructured":"Gil-Rodrigo A, Mir\u00f3 \u00d2, Pi\u00f1era P, et al. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in spanish emergency departments. Emergencias. 2020;32(4):233\u201341.","journal-title":"Emergencias"},{"key":"987_CR24","doi-asserted-by":"publisher","unstructured":"Shapiro RE, Gallardo VJ, Caronna E, Pozo-Rosich P. The impact of headache disorders on COVID-19 survival: a world population-based analysis. medRxiv. 2021. preprint. https:\/\/doi.org\/10.1101\/2021.03.10.21253280.","DOI":"10.1101\/2021.03.10.21253280"},{"key":"987_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.583870","volume":"11","author":"A Planchuelo-G\u00f3mez","year":"2020","unstructured":"Planchuelo-G\u00f3mez A, Trigo J, de Luis-Garc\u00eda R, et al. Deep phenotyping of headache in hospitalized COVID-19 patients via principal component analysis. Front Neurol. 2020;11: 583870. https:\/\/doi.org\/10.3389\/fneur.2020.583870.","journal-title":"Front Neurol"},{"issue":"4","key":"987_CR26","doi-asserted-by":"publisher","first-page":"00542","DOI":"10.1183\/23120541.00542-2020","volume":"6","author":"YMJ Go\u00ebrtz","year":"2020","unstructured":"Go\u00ebrtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542\u20132020. https:\/\/doi.org\/10.1183\/23120541.00542-2020.","journal-title":"ERJ Open Res"},{"issue":"10270","key":"987_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(20)32656-8.","journal-title":"Lancet"},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13054-016-1375-5","volume":"20","author":"EJ Walter","year":"2016","unstructured":"Walter EJ, Hanna-Jumma S, Carraretto M, Forni L. The pathophysiological basis and consequences of fever. Crit Care. 2016;20:200. https:\/\/doi.org\/10.1186\/s13054-016-1375-5.","journal-title":"Crit Care"},{"key":"987_CR29","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/head.13841","volume":"60","author":"R Belvis","year":"2020","unstructured":"Belvis R. Headaches during COVID-19: my clinical case and review of the literature. Headache. 2020;60:1422\u20136. https:\/\/doi.org\/10.1111\/head.13841.","journal-title":"Headache"},{"issue":"2","key":"987_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrmicro1343","volume":"4","author":"CC Bergmann","year":"2006","unstructured":"Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol. 2006;4(2):121\u201332. https:\/\/doi.org\/10.1038\/nrmicro1343.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"987_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","volume":"27","author":"L Yang","year":"2020","unstructured":"Yang L, Han Y, Nilsson-Payant BE, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27(1):125-136.e7. https:\/\/doi.org\/10.1016\/j.stem.2020.06.015.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"987_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/nejmc2019373","volume":"383","author":"IH Solomon","year":"2020","unstructured":"Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological features of COVID-19. N Engl J Med. 2020;383(10):989\u201392. https:\/\/doi.org\/10.1056\/nejmc2019373.","journal-title":"N Engl J Med"},{"key":"987_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbi.2020.04.017","volume":"88","author":"M Ye","year":"2020","unstructured":"Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020;88:945\u20136. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.017.","journal-title":"Brain Behav Immun"},{"key":"987_CR34","doi-asserted-by":"publisher","unstructured":"\u2022 Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168\u2013175. https:\/\/doi.org\/10.1038\/s41593-020-00758-5. This is the first study demonstrating the presence of SARS-CoV-2 protein in the trigeminal branches and the trigeminal ganglion. Their involvement could point to the activation of the trigeminovascular system, leading to headache.","DOI":"10.1038\/s41593-020-00758-5"},{"issue":"17","key":"987_CR35","doi-asserted-by":"publisher","first-page":"e00404","DOI":"10.1128\/jvi.00404-18","volume":"92","author":"M Dub\u00e9","year":"2018","unstructured":"Dub\u00e9 M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92(17):e00404-e418. https:\/\/doi.org\/10.1128\/jvi.00404-18.","journal-title":"J Virol"},{"issue":"2","key":"987_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"81","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;81(2):271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","journal-title":"Cell"},{"issue":"31","key":"987_CR37","doi-asserted-by":"publisher","first-page":"eabc5801","DOI":"10.1126\/sciadv.abc5801","volume":"6","author":"DH Brann","year":"2020","unstructured":"Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6(31):eabc5801. https:\/\/doi.org\/10.1126\/sciadv.abc5801.","journal-title":"Sci Adv"},{"key":"987_CR38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631\u20137. https:\/\/doi.org\/10.1002\/path.1570.","journal-title":"J Pathol"},{"key":"987_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2018.12.004","volume":"844","author":"P Conti","year":"2019","unstructured":"Conti P, D\u2019Ovidio C, Conti C, et al. Progression in migraine: role of mast cells and pro-inflammatory and anti-inflammatory cytokines. Eur J Pharmacol. 2019;844:87\u201394. https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.004.","journal-title":"Eur J Pharmacol"},{"key":"987_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1526-4610.2006.00337.x","volume":"46","author":"P Sarchielli","year":"2006","unstructured":"Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006;46:200\u20137. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00337.x.","journal-title":"Headache"},{"issue":"8","key":"987_CR41","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua G, Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575\u201382. https:\/\/doi.org\/10.1016\/S2352-3026(20)30216-7.","journal-title":"Lancet Haematol"},{"issue":"9","key":"987_CR42","doi-asserted-by":"publisher","first-page":"879","DOI":"10.14670\/HH-11-881","volume":"32","author":"C Kaur","year":"2017","unstructured":"Kaur C, Ling EA. The circumventricular organs. Histol Histopathol. 2017;32(9):879\u201392. https:\/\/doi.org\/10.14670\/HH-11-881.","journal-title":"Histol Histopathol"},{"key":"987_CR43","doi-asserted-by":"publisher","unstructured":"Nampoothiri S, Sauve F, Ternier G, et al. The hypothalamus as a hub for putative SARS-CoV-2 brain infection. bioRxiv. 2020. preprint. https:\/\/doi.org\/10.1101\/2020.06.08.139329","DOI":"10.1101\/2020.06.08.139329"},{"issue":"Pt 7","key":"987_CR44","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/brain\/aww097","volume":"139","author":"LH Schulte","year":"2016","unstructured":"Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987\u201393. https:\/\/doi.org\/10.1093\/brain\/aww097.","journal-title":"Brain"},{"key":"987_CR45","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"95","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;95:1033\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0.","journal-title":"Lancet"},{"key":"987_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. Il-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6: a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"987_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020;55: 105954. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105954.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"987_CR48","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","volume":"19","author":"A D\u2019Alessandro","year":"2020","unstructured":"D\u2019Alessandro A, Thomas T, Dzieciatkowska M, et al. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J Proteome Res. 2020;19(11):4417\u201327. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00365.","journal-title":"J Proteome Res"},{"key":"987_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12974-016-0607-6","volume":"13","author":"YQ Zhou","year":"2016","unstructured":"Zhou YQ, Liu Z, Liu ZH, et al. Interleukin-6: an emerging regulator of pathological pain. J Neuroinflammation. 2016;13:141. https:\/\/doi.org\/10.1186\/s12974-016-0607-6.","journal-title":"J Neuroinflammation"},{"key":"987_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8069-8-6","volume":"8","author":"J Yan","year":"2012","unstructured":"Yan J, Melemedjian OK, Price TJ, Dussor G. Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain. 2012;8:6. https:\/\/doi.org\/10.1186\/1744-8069-8-6.","journal-title":"Mol Pain"},{"issue":"5","key":"987_CR51","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s10072-020-04978-2","volume":"42","author":"\u00d6 Karada\u015f","year":"2021","unstructured":"Karada\u015f \u00d6, \u00d6zt\u00fcrk B, Sonkaya AR, Ta\u015fdelen B, \u00d6zge A, Bolay H. Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6. Neurol Sci. 2021;42(5):1665\u201373. https:\/\/doi.org\/10.1007\/s10072-020-04978-2.","journal-title":"Neurol Sci"},{"issue":"4","key":"987_CR52","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94(4):1099\u2013142. https:\/\/doi.org\/10.1152\/physrev.00034.2013.","journal-title":"Physiol Rev"},{"issue":"2\u20133","key":"987_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0162-3109(97)00055-6","volume":"37","author":"SD Brain","year":"1997","unstructured":"Brain SD. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology. 1997;37(2\u20133):133\u201352. https:\/\/doi.org\/10.1016\/S0162-3109(97)00055-6.","journal-title":"Immunopharmacology"},{"issue":"1","key":"987_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-011-1161-2","volume":"45","author":"B Holzmann","year":"2013","unstructured":"Holzmann B. Modulation of immune responses by the neuropeptide CGRP. Amino Acids. 2013;45(1):1\u20137. https:\/\/doi.org\/10.1007\/s00726-011-1161-2.","journal-title":"Amino Acids"},{"issue":"11","key":"987_CR55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41582-020-0402-y","volume":"16","author":"F De Virgilis","year":"2020","unstructured":"De Virgilis F, Di Giovanni S. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat Rev Neurol. 2020;16(11):645\u201352. https:\/\/doi.org\/10.1038\/s41582-020-0402-y.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"987_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183\u20137. https:\/\/doi.org\/10.1002\/ana.410280213.","journal-title":"Ann Neurol"},{"issue":"3","key":"987_CR57","doi-asserted-by":"publisher","first-page":"bvaa199","DOI":"10.1210\/jendso\/bvaa199","volume":"5","author":"L Ochoa-Callejero","year":"2021","unstructured":"Ochoa-Callejero L, Garc\u00eda-Sanmart\u00edn J, Villoslada-Blanco P, et al. Circulating levels of calcitonin gene-related peptide (CGRP) are lower in COVID-19 patients. J Endocr Soc. 2021;5(3):bvaa199. https:\/\/doi.org\/10.1210\/jendso\/bvaa199.","journal-title":"J Endocr Soc"},{"issue":"10210","key":"987_CR58","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","volume":"394","author":"A Charles","year":"2019","unstructured":"Charles A, Pozo-Rosich P. Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet. 2019;394(10210):1765\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(19)32504-8.","journal-title":"Lancet"},{"key":"987_CR59","unstructured":"Safety and efficacy trial of zavegepant intranasal for hospitalized patients with COVID-19 requiring supplemental oxygen. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT04346615?view=results. Accessed 15 Mar 2021."},{"issue":"3","key":"987_CR60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pain.2006.09.017","volume":"128","author":"E Fusayasu","year":"2007","unstructured":"Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain. 2007;128(3):209\u201314. https:\/\/doi.org\/10.1016\/j.pain.2006.09.017.","journal-title":"Pain"},{"issue":"4","key":"987_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11940-016-0397-2","volume":"8","author":"RB Halker","year":"2016","unstructured":"Halker RB, Starling AJ, Vargas BB, Schwedt TJ. ACE and ARB agents in the prophylactic therapy of migraine\u2014how effective are they? Curr Treat Options Neurol. 2016;8(4):15. https:\/\/doi.org\/10.1007\/s11940-016-0397-2.","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"987_CR62","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/nu12040988","volume":"12","author":"WB Grant","year":"2020","unstructured":"Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988. https:\/\/doi.org\/10.3390\/nu12040988.","journal-title":"Nutrients"},{"issue":"1","key":"987_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/nu12010243","volume":"12","author":"M Nowaczewska","year":"2020","unstructured":"Nowaczewska M, Wici\u0144ski M, Osi\u0144ski S, K\u00e1zmierczak H. The role of vitamin D in primary headache\u2013from potential mechanism to treatment. Nutrients. 2020;12(1):243. https:\/\/doi.org\/10.3390\/nu12010243.","journal-title":"Nutrients"},{"issue":"7608","key":"987_CR64","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature18283","volume":"534","author":"MJ Vasek","year":"2016","unstructured":"Vasek MJ, Garber C, Dorsey D, et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016;534(7608):538\u201343. https:\/\/doi.org\/10.1038\/nature18283.","journal-title":"Nature"},{"key":"987_CR65","doi-asserted-by":"publisher","unstructured":"Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0500","DOI":"10.1001\/jamapsychiatry.2021.0500"},{"issue":"1","key":"987_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/head.12732","volume":"56","author":"R Noruzzadeh","year":"2016","unstructured":"Noruzzadeh R, Modabbernia A, Aghamollaii V, et al. Memantine for prophylactic treatment of migraine without aura: a randomized double-blind placebo-controlled study. Headache. 2016;56(1):95\u2013103. https:\/\/doi.org\/10.1111\/head.12732.","journal-title":"Headache"},{"issue":"1","key":"987_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-020-01106-5","volume":"21","author":"A Maassenvandenbrink","year":"2020","unstructured":"Maassenvandenbrink A, De Vries T, Danser AHJ. Headache medication and the COVID-19 pandemic. J Headache Pain. 2020;21(1):38. https:\/\/doi.org\/10.1186\/s10194-020-01106-5.","journal-title":"J Headache Pain"},{"issue":"8","key":"987_CR68","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/head.13903","volume":"60","author":"KN Arca","year":"2020","unstructured":"Arca KN, Smith JH, Chiang CC, et al. COVID-19 and headache medicine: a narrative review of non-steroidal anti-inflammatory drug (NSAID) and corticosteroid use. Headache. 2020;60(8):1558\u201368. https:\/\/doi.org\/10.1111\/head.13903.","journal-title":"Headache"},{"issue":"1","key":"987_CR69","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","volume":"24","author":"J van Paassen","year":"2020","unstructured":"van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020;24(1):696. https:\/\/doi.org\/10.1186\/s13054-020-03400-9.","journal-title":"Crit Care"},{"issue":"19","key":"987_CR70","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","volume":"106","author":"J Hippisley-Cox","year":"2020","unstructured":"Hippisley-Cox J, Young D, Coupland C, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106(19):1503\u201311. https:\/\/doi.org\/10.1136\/heartjnl-2020-317393.","journal-title":"Heart"},{"issue":"21","key":"987_CR71","doi-asserted-by":"publisher","first-page":"00056","DOI":"10.1016\/j.nrl.2021.03.003","volume":"S0213\u20134853","author":"E Caronna","year":"2021","unstructured":"Caronna E, Gallardo VJ, Alpuente A, et al. Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: present and future implications. Neurologia. 2021;S0213\u20134853(21):00056\u201366. https:\/\/doi.org\/10.1016\/j.nrl.2021.03.003.","journal-title":"Neurologia"},{"issue":"2","key":"987_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1590\/S0074-02761986000200019","volume":"81","author":"HG Schatzmayr","year":"1986","unstructured":"Schatzmayr HG, Nogueira RM, da Rosa APT. An outbreak of dengue virus at Rio de Janeiro\u20131986. Mem Inst Oswaldo Cruz. 1986;81(2):245\u20136. https:\/\/doi.org\/10.1590\/S0074-02761986000200019.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"987_CR73","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jiph.2019.07.006","volume":"13","author":"B Joob","year":"2020","unstructured":"Joob B, Wiwanitkit V. Clinical relevance of Zika symptoms in the context of a Zika dengue epidemic. J Infect Public Health. 2020;13(1):158. https:\/\/doi.org\/10.1016\/j.jiph.2019.07.006.","journal-title":"J Infect Public Health"},{"issue":"10","key":"987_CR74","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/head.13183","volume":"57","author":"PA Sampaio Rocha-Filho","year":"2017","unstructured":"Sampaio Rocha-Filho PA, Torres RCS, Ramos MU. HIV and headache: a cross-sectional study. Headache. 2017;57(10):1545\u201350. https:\/\/doi.org\/10.1111\/head.13183.","journal-title":"Headache"},{"issue":"13","key":"987_CR75","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1177\/0333102420965132","volume":"40","author":"TD Rozen","year":"2020","unstructured":"Rozen TD. Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: lessons from the 1890 Russian\/Asiatic flu. Cephalalgia. 2020;40(13):1406\u20139. https:\/\/doi.org\/10.1177\/0333102420965132.","journal-title":"Cephalalgia"},{"issue":"2","key":"987_CR76","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0830","volume":"4","author":"JK Logue","year":"2021","unstructured":"Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2): e210830. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0830.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"987_CR77","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/head.14059","volume":"61","author":"E Caronna","year":"2021","unstructured":"Caronna E, Pozo-Rosich P. Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders. Headache. 2021;61(2):385\u20136. https:\/\/doi.org\/10.1111\/head.14059.","journal-title":"Headache"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-021-00987-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-021-00987-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-021-00987-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T19:05:36Z","timestamp":1639595136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-021-00987-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":77,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1007\/s11916-021-00987-8","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"9 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr Caronna has received honoraria from Novartis and Chiesi. Dr Pozo-Rosich has received honoraria as a consultant and speaker for the following: Allergan-AbbVie, Almirall, Biohaven, Chiesi, Eli Lilly, Medscape, Neurodiem, Novartis, and Teva. Her research group has received research grants from Novartis and has received funding for clinical trials from Alder, Amgen, Electrocore, Eli Lilly, Novartis, Teva. She is a trustee member of the board of the International Headache Society and the Council of the European Headache Federation. She is on the editorial board of Revista de Neurologia. She is an editor for Cephalalgia, Headache, Neurologia, Frontiers of Neurology, and advisor for The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of . PP-R does not own stocks from any pharmaceutical company. The authors declare no conflict of interest in regard to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"73"}}